SANTA MONICA, Calif., July 6, 2011 /PRNewswire/ -- Derycz Scientific, Inc., (OTC Bulletin Board: DYSC), a company that is pioneering a fresh way of facilitating the flow of information from content publishers to enterprise customers and their constituents, has retained the Investor Relations Group (IRG), a fourteen-year-old, award-winning corporate communications firm based in New York City, to serve as its investor relations and public relations firm. IRG will harness a range of strategies to help Derycz Scientific markets its services within more than 100 countries in which the Company currently conducts business. Additionally, IRG will strive to raise awareness of Derycz Scientific's capabilities as the Company seeks to increase its already global footprint.
IRG's investor relations team will target specific portfolio managers and equity analysts in the professional investment community to increase awareness of Derycz Scientific's efforts to facilitate the dissemination of published information. Concurrent with that effort, the public relations team will initiate an outreach campaign targeting editors, writers, and segment producers of local and national trade and consumer online, print, radio, and broadcast media outlets worldwide.
"This is an exciting time for Derycz Scientific," said Peter Derycz, Chairman and Chief Executive Officer of Derycz Scientific, Inc. "We have spent the past several years reconceptualizing the relationship between content providers and their customers, focusing initially on the life science markets. We feel that our efforts to widen the accessibility of published information, and to help users navigate the pitfalls of content reproduction, sharing and dissemination, will assist a broad range of companies, institutions, and individuals to better meet their goals."
Mr. Derycz continued: "As we continue to reach our milestones, we look forward to working with IRG to communicate our company strategy, goals and progress with the investment community, our shareholders, the media, content providers and their customers, and the public-at-large."
IRG's corporate communications program includes new media and multimedia initiatives that involve the creation of broadcast-ready corporate videos, podcasts, and the creation of social networking and video service accounts. The Investor Relations Group is a multiple winner of the "Stevie Award" for Investor Relations, and was named a finalist in the Best Media Website category from the 2009 American Business Awards.
About The Investor Relations Group, Inc.
The Investor Relations Group, Inc. (IRG) offers a full-service corporate communications program designed to suit the many unique needs of Alternative Public Offering (APO) companies. The program utilizes a proprietary, targeted approach to reach institutional investors, analysts, and the media-at-large. For further information, please visit the company's website at http://www.investorrelationsgroup.com.
About Derycz Scientific®
Derycz Scientific, Inc. develops companies, products, services and systems that facilitate the re-use of published content in a manner that helps organizations achieve their marketing, communication and research goals effectively and in compliance with copyright law and regulatory rules. Its subsidiary companies include Reprints Desk, Inc., Pools Press, Inc. and the newly acquired Techniques Appliquees aux Arts Graphiques, S.p.A. (TAAG). Reprints Desk offers a one-stop solution for reprints, ePrints and single articles, and has delivered millions of articles worldwide. Reprints Desk is an innovator in content retrieval and ePrint delivery, with services designed to help make effective use of published articles in a copyright-compliant manner. Pools Press has excelled in the reprint market for more than 30 years. It provides professionally printed articles from medical and technical journals; prints booklets, catalogs, pamphlets, direct mail pieces and newsletters; and works with publishers who wish to outsource a portion of or all of their reprints business. TAAG offers printing, distribution and information logistics services, with core competencies in the professional production and distribution of clinical trial kits and clinical article reprints for the life sciences industry. For more information, please visit www.deryczscientific.com.
Certain matters discussed in this press release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; acceptance of the Company's products in the market; the Company's success in obtaining new customers; the Company's success in technology and product development; the Company's ability to execute its business model and strategic plans; the Company's success in integrating acquired entities and assets, and all the risks and related information described from time to time in the Company's filings with the Securities and Exchange Commission ("SEC"), including the financial statements and related information contained in the Company's Annual Report on Form 10-K. The Company assumes no obligation to update the cautionary information in this release.
SOURCE Derycz Scientific, Inc.